Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.39 |
| ▸ | MME | P08473 | 3/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11575487 | 0.74 | CTSB (0.39) | ACE | |
| SCHEMBL30799577 | 0.74 | MME (0.60) | RENMME | |
| SCHEMBL1674750 | 0.73 | ALDH1A1 (0.53) | MME | |
| SCHEMBL18613505 | 0.73 | ALDH1A1 (0.53) | MME | |
| SCHEMBL1674751 | 0.73 | ALDH1A1 (0.53) | MME | |
| SCHEMBL8074243 | 0.73 | GPR88 (0.44) | — | |
| SCHEMBL8074241 | 0.73 | GPR88 (0.44) | — | |
| SCHEMBL8060317 | 0.70 | MME (0.59) | RENMMEACE | |
| SCHEMBL21192611 | 0.70 | ACE (0.57) | RENMMEACE | |
| SCHEMBL21192616 | 0.70 | ACE (0.57) | RENMMEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007090094-A3 | THERMALLY-TARGETED DELIVERY OF MEDICAMENTS, INCLUDING DOXORUBICIN | UNIV MISSISSIPPI MEDICAL CT (US) | 2009-04-02 | — | — | WO | disclosed |
| EP-1981527-A2 | THERMALLY-TARGETED DELIVERY OF MEDICAMENTS, INCLUDING DOXORUBICIN | The University of Mississippi Medical Center (US) | 2008-10-22 | — | — | EP | disclosed |
| WO-2007090094-A2 | THERMALLY-TARGETED DELIVERY OF MEDICAMENTS, INCLUDING DOXORUBICIN | THE UNIVERSITY OF MISSISSIPPI MEDICAL CENTER (US) | 2007-08-09 | — | — | WO | disclosed |